Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

SELL
$532.27 - $656.65 $532 - $656
-1 Reduced 5.88%
16 $8.82 Million
Q1 2025

Apr 29, 2025

BUY
$571.0 - $671.75 $1,142 - $1,343
2 Added 13.33%
17 $10.1 Million
Q4 2024

Jan 30, 2025

BUY
$520.52 - $638.33 $7,807 - $9,574
15 New
15 $9.23 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $50.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Sierra Ocean, LLC Portfolio

Follow Sierra Ocean, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Ocean, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Ocean, LLC with notifications on news.